Lemaitre Vascular Inc
LMATNasdaqCIK 1158895HealthcareFiscal year ends Dec 31
Reports and events: 237 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1520:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-422885 |
| 2026-08-0510:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333762 |
| 2026-08-0420:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332982 |
| 2026-06-0523:41 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257978 |
| 2026-05-0610:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-207500 |
| 2026-05-0520:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206578 |
| 2026-04-1411:33 ET | DEF 14A | Proxy statementPeriod 2026-04-13 | 0001193125-26-153877 |
| 2026-04-1410:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-26-153779 |
| 2026-02-2612:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073360 |
| 2026-02-2521:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071954 |
| 2025-11-0711:59 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-270981 |
| 2025-11-0702:00 ET | 8-K/A | 5.07 Shareholder vote results | 0001193125-25-270458 |
| 2025-11-0621:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269454 |
| 2025-08-0610:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-024936 |
| 2025-08-0520:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-024862 |
| 2025-06-0321:01 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-019314 |
| 2025-05-0820:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015479 |
| 2025-05-0120:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-014093 |
| 2025-04-1714:11 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001437749-25-012238 |
| 2025-02-2817:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-005637 |
| 2025-02-2721:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005495 |
| 2025-02-1314:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-003679 |
| 2024-12-1921:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-130155 |
| 2024-12-1711:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129159 |
| 2024-12-1612:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-128674 |
| 2024-11-0816:31 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034124 |
| 2024-10-3120:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-032784 |
| 2024-08-2620:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-24-027754 |
| 2024-08-0818:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025466 |
| 2024-08-0120:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-024304 |
| 2024-06-0320:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-019032 |
| 2024-05-1015:26 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-015899 |
| 2024-05-0220:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014372 |
| 2024-04-1616:01 ET | DEF 14A | Proxy statementPeriod 2024-06-03 | 0001437749-24-012147 |
| 2024-02-2918:34 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-006037 |
| 2024-02-2722:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-005732 |
| 2023-11-0719:56 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-030613 |
| 2023-11-0120:47 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-029792 |
| 2023-08-0816:56 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-022476 |
| 2023-08-0120:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021414 |
| 2023-06-0610:02 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-016676 |
| 2023-05-0920:28 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-013314 |
| 2023-05-0220:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-012106 |
| 2023-04-1412:30 ET | DEF 14A | Proxy statement | 0001437749-23-010217 |
| 2023-03-0118:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001437749-23-005056 |
| 2023-02-2320:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-004378 |
| 2022-11-0821:34 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001437749-22-026383 |
| 2022-10-2720:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-024955 |
| 2022-09-2312:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-22-022937 |
| 2022-08-0510:10 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001437749-22-019001 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.